Vernieri C, Prisciandaro M, Milano M, Cona MS, Maggi C, Brambilla M, Mennitto A, Fabbroni C, Farè E, Cresta S, Celio L, Mariani G, Bianchi G, Capri G, de Braud F

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles.

Clin Breast Cancer 2019; e306-e318. doi: 10.1016/j.clbc.2018.12.004

Sapienza MR, Abate F, Melle F, Orecchioni S, Fuligni F, Etebari M, Tabanelli V, Laginestra MA, Pileri A, Motta G, Rossi M, Agostinelli C, Sabattini E, Pimpinelli N, Truni M, Falini B, Cerroni L, Talarico G, Piccioni R, Amente S, Indio V, Tarantino G, Brundu F, Paulli M, Berti E, Facchetti F, Dellino GI, Bertolini F, Tripodo C, Rabadan R, Pileri SA

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.

Haematologica 2019; 729-737. doi: 10.3324/haematol.2018.202093

Jachetti E, D'Incà F, Danelli L, Magris R, Dal Secco C, Vit F, Cancila V, Tripodo C, Scapini P, Colombo MP, Pucillo C, Frossi B

Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activity.

J Leukoc Biol 2019; 633-644. doi: 10.1002/JLB.4HI1018-390R

Barger SR, Reilly NS, Shutova MS, Li Q, Maiuri P, Heddleston JM, Mooseker MS, Flavell RA, Svitkina T, Oakes PW, Krendel M, Gauthier NC

Membrane-cytoskeletal crosstalk mediated by myosin-I regulates adhesion turnover during phagocytosis.

Nat Commun 2019; 1249. doi: 10.1038/s41467-019-09104-1

Teza G, Suweis S, Gherardi M, Maritan A, Cosentino Lagomarsino M

Network model of conviction-driven social segregation.

Phys Rev E 2019; 032310. doi: 10.1103/PhysRevE.99.032310

Vernieri C, Galli F, Ferrari L, Marchetti P, Lonardi S, Maiello E, Iaffaioli RV, Zampino MG, Zaniboni A, De Placido S, Banzi M, Damiani A, Ferrari D, Rosati G, Labianca RF, Bidoli P, Frassineti GL, Nicolini M, Pavesi L, Tronconi MC, Buonadonna A, Ferrario S, Re GL, Adamo V, Tamburini E, Clerico M, Giordani P, Leonardi F, Barni S, Ciarlo A, Cavanna L, Gori S, Cinieri S, Faedi M, Aglietta M, Antista M, Dotti KF, Galli F, Di Bartolomeo M

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.

Oncologist 2019; 385-393. doi: 10.1634/theoncologist.2018-0442

Cona MS, Lecchi M, Cresta S, Damian S, Del Vecchio M, Necchi A, Poggi MM, Raggi D, Randon G, Ratta R, Signorelli D, Vernieri C, de Braud F, Verderio P, Di Nicola M

Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies.

Cancers (Basel) 2019; . doi: 10.3390/cancers11020223

Lo Russo G, Moro M, Sommariva M, Cancila V, Boeri M, Centonze G, Ferro S, Ganzinelli M, Gasparini P, Huber V, Milione M, Porcu L, Proto C, Pruneri G, Signorelli D, Sangaletti S, Sfondrini L, Storti C, Tassi E, Bardelli A, Marsoni S, Torri V, Tripodo C, Colombo MP, Anichini A, Rivoltini L, Balsari A, Sozzi G, Garassino MC

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade.

Clin Cancer Res 2019; 989-999. doi: 10.1158/1078-0432.CCR-18-1390

Mauri G, Pizzutilo EG, Amatu A, Bencardino K, Palmeri L, Bonazzina EF, Tosi F, Carlo Stella G, Burrafato G, Scaglione F, Marsoni S, Siravegna G, Bardelli A, Siena S, Sartore-Bianchi A

Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies.

Cancer Treat Rev 2019; 41-53. doi: 10.1016/j.ctrv.2018.12.006

Zucchelli C, Tamburri S, Filosa G, Ghitti M, Quilici G, Bachi A, Musco G

Sp140 is a multi-SUMO-1 target and its PHD finger promotes SUMOylation of the adjacent Bromodomain.

Biochim Biophys Acta Gen Subj 2019; 456-465. doi: 10.1016/j.bbagen.2018.11.011

Ourak M, Smits J, Esteveny L, Borghesan G, Gijbels A, Schoevaerdts L, Douven Y, Scholtes J, Lankenau E, Eixmann T, Schulz-Hildebrandt H, Hüttmann G, Kozlovszky M, Kronreif G, Willekens K, Stalmans P, Faridpooya K, Cereda M, Giani A, Staurenghi G, Reynaerts D, Vander Poorten EB

Combined OCT distance and FBG force sensing cannulation needle for retinal vein cannulation: in vivo animal validation.

Int J Comput Assist Radiol Surg 2019; 301-309. doi: 10.1007/s11548-018-1829-0

Castagnoli L, Mandaliti W, Nepravishta R, Valentini E, Mattioni A, Procopio R, Iannuccelli M, Polo S, Paci M, Cesareni G, Santonico E

Selectivity of the CUBAN domain in the recognition of ubiquitin and NEDD8.

FEBS J 2019; 653-677. doi: 10.1111/febs.14752

Castagnoli L, Iorio E, Dugo M, Koschorke A, Faraci S, Canese R, Casalini P, Nanni P, Vernieri C, Di Nicola M, Morelli D, Tagliabue E, Pupa SM

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer.

J Cell Physiol 2019; 1768-1779. doi: 10.1002/jcp.27049

Osti D, Del Bene M, Rappa G, Santos M, Matafora V, Richichi C, Faletti S, Beznoussenko GV, Mironov A, Bachi A, Fornasari L, Bongetta D, Gaetani P, DiMeco F, Lorico A, Pelicci G

Clinical Significance of Extracellular Vesicles in Plasma from Glioblastoma Patients.

Clin Cancer Res 2019; 266-276. doi: 10.1158/1078-0432.CCR-18-1941

Gruarin P, Maglie S, De Simone M, Häringer B, Vasco C, Ranzani V, Bosotti R, Noddings JS, Larghi P, Facciotti F, Sarnicola ML, Martinovic M, Crosti M, Moro M, Rossi RL, Bernardo ME, Caprioli F, Locatelli F, Rossetti G, Abrignani S, Pagani M, Geginat J

Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells.

Eur J Immunol 2019; 96-111. doi: 10.1002/eji.201847722

Ardelt MA, Fröhlich T, Martini E, Müller M, Kanitz V, Atzberger C, Cantonati P, Meßner M, Posselt L, Lehr T, Wojtyniak JG, Ulrich M, Arnold GJ, König L, Parazzoli D, Zahler S, Rothenfußer S, Mayr D, Gerbes A, Scita G, Vollmar AM, Pachmayr J

Inhibition of Cyclin-Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy.

Hepatology 2019; 376-393. doi: 10.1002/hep.30190

Amatu A, Schirripa M, Tosi F, Lonardi S, Bencardino K, Bonazzina E, Palmeri L, Patanè DA, Pizzutilo EG, Mussolin B, Bergamo F, Alberti G, Intini R, Procaccio L, Arese M, Marsoni S, Nichelatti M, Zagonel V, Siena S, Bardelli A, Loupakis F, Di Nicolantonio F, Sartore-Bianchi A, Barault L

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib.

Front Oncol 2019; 622. doi: 10.3389/fonc.2019.00622

Martano G, Borroni EM, Lopci E, Cattaneo MG, Mattioli M, Bachi A, Decimo I, Bifari F

Metabolism of Stem and Progenitor Cells: Proper Methods to Answer Specific Questions.

Front Mol Neurosci 2019; 151. doi: 10.3389/fnmol.2019.00151

Morandi E, Cereda M, Incarnato D, Parlato C, Basile G, Anselmi F, Lauria A, Simon LM, Laurence Polignano I, Arruga F, Deaglio S, Tirtei E, Fagioli F, Oliviero S

HaTSPiL: A modular pipeline for high-throughput sequencing data analysis.

PLoS One 2019; e0222512. doi: 10.1371/journal.pone.0222512

Fucà G, Galli G, Poggi M, Lo Russo G, Proto C, Imbimbo M, Ferrara R, Zilembo N, Ganzinelli M, Sica A, Torri V, Colombo MP, Vernieri C, Balsari A, de Braud F, Garassino MC, Signorelli D

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.

ESMO Open 2019; e000457. doi: 10.1136/esmoopen-2018-000457

Sangaletti S, Talarico G, Chiodoni C, Cappetti B, Botti L, Portararo P, Gulino A, Consonni FM, Sica A, Randon G, Di Nicola M, Tripodo C, Colombo MP

SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.

Front Immunol 2019; 1369. doi: 10.3389/fimmu.2019.01369

Di Cosimo S, La Verde N, Moretti A, Cazzaniga ME, Generali D, Bianchi GV, Mariani L, Torri V, Crippa F, Paolini B, Scaperrotta G, De Santis MC, Di Nicola M, Apolone G, Gulino A, Tripodo C, Colombo MP, Folli S, de Braud F

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study.

PLoS One 2019; e0220644. doi: 10.1371/journal.pone.0220644

D'Alessandro G, Whelan DR, Howard SM, Vitelli V, Renaudin X, Adamowicz M, Iannelli F, Jones-Weinert CW, Lee M, Matti V, Lee WTC, Morten MJ, Venkitaraman AR, Cejka P, Rothenberg E, d'Adda di Fagagna F

BRCA2 controls DNA:RNA hybrid level at DSBs by mediating RNase H2 recruitment.

Nat Commun 2018; 5376. doi: 10.1038/s41467-018-07799-2

Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, Tregnago C, Corrado M, Pigazzi M, Barnaba V, Tripodo C, Matarese G, Piconese S, Campello S

Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming.

Cell Rep 2018; 3059-3073.e10. doi: 10.1016/j.celrep.2018.11.018

%PLACEHOLDER%